Spectroscopic and computational insights into theophylline/β-cyclodextrin complexation: inclusion accomplished by diverse methods

References

• Ammar, H.O., et al., 1996. Improvement of some pharmaceutical properties of drugs by cyclodextrin complexation. 5. Theophylline. Die pharmazie, 51 (1), 42–46.
   PubMed Web of Science ®Google Scholar
• Barnes, P.J., 2003. Theophylline: new perspectives for an old drug. American journal of respiratory and critical care medicine, 167 (6), 813–818.
   PubMed Web of Science ®Google Scholar
• Brewster, M.E. and Loftsson, T., 2007. Cyclodextrins as pharmaceutical solubilizers. Advanced drug delivery reviews, 59 (7), 645–666.
   PubMed Web of Science ®Google Scholar
• Chadha, R., et al., 2011. Characterization and in vivo efficacy of inclusion complexes of sulphadoxine with β-cyclodextrin: calorimetric and spectroscopic studies. Journal of inclusion phenomena and macrocyclic chemistry, 71 (1–2), 149–159.
   Web of Science ®Google Scholar
• Chakraborty, S., et al., 2010. Inclusion of chrysin in β-cyclodextrin nanocavity and its effect on antioxidant potential of chrysin: a spectroscopic and molecular modeling approach. Journal of molecular structure, 977 (1–3), 180–188.
   Web of Science ®Google Scholar
• Challa, R., et al., 2005. Cyclodextrins in drug delivery: an updated review. AAPS PharmSciTech, 6 (2), E329–E357.
   PubMed Web of Science ®Google Scholar
• Cruz, A.A., Stelmach, R., and Ponte, E.V., 2017. Asthma prevalence and severity in low-resource communities. Current opinion in allergy and clinical immunology, 17 (3), 188–193.
   PubMed Web of Science ®Google Scholar
• Das, S. and Subuddhi, U., 2015. Studies on the complexation of diclofenac sodium with β − cyclodextrin: influence of method of preparation. Journal of molecular structure, 1099, 482–489.
   Web of Science ®Google Scholar
• Donoso, P., et al., 1994. Comparison of the effects of caffeine and other methylxanthines on [Ca2+] in rat ventricular myocytes. British journal of pharmacology, 111 (2), 455–458.
   PubMed Web of Science ®Google Scholar
• Ellwood, P., et al., 2017. The Global Asthma Network rationale and methods for phase I global surveillance: prevalence, severity, management and risk factors. European respiratory journal, 49 (1), 1601605.
   PubMed Web of Science ®Google Scholar
• Erdan, N. and Celebi, N., 1998. A study on the inclusion complex of naproxen with β-cyclodextrin. International journal of pharmaceutics, 48, 83–89.
   Web of Science ®Google Scholar
• Fernandes, A., et al., 2014. Structural characterization of inclusion complexes between cycnidi-3-O-glucoside and β−cyclodextrin. Carbohydrate polymers, 102, 269–277.
   PubMed Web of Science ®Google Scholar
• Greatbanks, D. and Pickford, R., 1987. Cyclodextrins as chiral complexing agents in water, and their applications to optical purity measurements. Magnetic resonance in chemistry, 25 (3), 208–213.
   Web of Science ®Google Scholar
• Higuchi, T. and Connors, K., 1965. Phase solubility technique. Advance analytical chemistry instruments, 4, 117–212.
   Google Scholar
• Hirlekar, R. and Kadam, V., 2009. Preparation and characterization of inclusion complexes of carvedilol with methyl-β-cyclodextrin. Journal of inclusion phenomena and macrocyclic chemistry, 63 (3–4), 219–224.
   Web of Science ®Google Scholar
• Job, P., 1928. Formation and stability of inorganic complexes in solution. Annali di chimica, 9, 113–203.
   Google Scholar
• Li, J. and Zhang, X., 2011. Preparation and characterization of the inclusion complex of ofloxacin with β-CD and HP-β-CD. Journal of inclusion phenomena and macrocyclic chemistry, 69 (1–2), 173–179.
   Web of Science ®Google Scholar
• Lundbäck, B., et al., 2016. Is asthma prevalence still increasing? Expert review of respiratory medicine, 10 (1), 39–51.
   PubMed Web of Science ®Google Scholar
• Marques, H.C., Hadgraft, J., and Kellaway, I., 1990. Studies of cyclodextrin inclusion complexes. I. The salbutamol-cyclodextrin complex as studied by phase solubility and DSC. International journal of pharmaceutics, 63 (3), 259–266.
   Web of Science ®Google Scholar
• Miletic, T., et al., 2013. Spray-dried voriconazole-cyclodextrin complexes: solubility, dissolution rate and chemical stability. Carbohydrate polymers, 98 (1), 122–131.
   PubMed Web of Science ®Google Scholar
• Miquel, S., et al., 2016. Anti-biofilm activity as a health issue. Frontiers in microbiology, 7, 592.
   PubMed Web of Science ®Google Scholar
• Mohit, V., et al., 2010. Effect of preparation method on complexation of cefdinir with β-cyclodextrin. Journal of inclusion phenomena and macrocyclic chemistry, 67 (1–2), 39–47.
   Web of Science ®Google Scholar
• Mokhtar, M. and Adnan, R., 2012. Preparation method and characterization of inclusion complex of theophylline/beta cyclodextrin. ESTEEM academic journal, 8, 50–63.
   Google Scholar
• Morris, G.M., et al., 1998. Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. Journal of computational chemistry, 19 (14), 1639–1662.
   Web of Science ®Google Scholar
• Mura, P., et al., 1999. Influence of the preparation method on the physicochemical properties of ketoprofen-cyclodextrin binary systems. International journal of pharmaceutics, 179 (1), 117–128.
   PubMed Web of Science ®Google Scholar
• National Institute of Health, Guidelines for the diagnosis and management of asthma. 1991. National asthma education program expert panel report. DHHS publication No. 91: 3042.
   Google Scholar
• Ouyang, D., et al., 2010. Structure and dynamics of multiple cationic vectors-siRNA complexation by all-atomic molecular dynamics simulations. The journal of physical chemistry B, 114 (28), 9231–9237.
   PubMed Web of Science ®Google Scholar
• Pina, M.E. and Veiga, F., 2000. The influence of diluent on the release of theophylline from hydrophilic matrix tablets. Drug development and industrial pharmacy, 26 (10), 1125–1128.
   PubMed Web of Science ®Google Scholar
• Polshettiwar, V. and Varma, R.S., 2008. Aqueous microwave chemistry: a clean and green synthetic tool for rapid drug discovery. Chemical society reviews, 37 (8), 1546–1557.
   PubMed Web of Science ®Google Scholar
• Popa, N., et al., 2010. Hydrogels based on chitosan-xanthan for controlled release of theophylline. Journal of materials science. Materials in medicine, 21 (4), 1241–1248.
   PubMed Web of Science ®Google Scholar
• Priya, A.S., et al., 2013. Improvement on dissolution rate of inclusion complex of rifabutin drug with β-cyclodextrin. International journal of biological macromolecules, 62, 472–480.
   PubMed Web of Science ®Google Scholar
• Ram, F.S.F., et al., 2005. Efficacy of theophylline in people with stable chronic obstructive pulmonary disease: a systematic review and meta-analysis. Respiratory medicine, 99 (2), 135–144.
   PubMed Web of Science ®Google Scholar
• Salustio, P.J., et al., 2011. Advanced technologies for oral controlled release: cyclodextrins for oral controlled release. AAPS PharmSciTech, 12 (4), 1276–1292.
   PubMed Web of Science ®Google Scholar
• Santos, C., et al., 2012. A comparison between the diffusion properties of theophylline/β-cyclodextrin and theophylline/2-hydroxypropyl-β-cyclodextrin in aqueous systems. Journal of chemical and engineering data, 57 (7), 1881–1886.
   Web of Science ®Google Scholar
• Schneider, H.-J., et al., 1998. NMR studies of cyclodextrins and cyclodextrin complexes. Chemical reviews, 98 (5), 1755–1785.
   PubMed Web of Science ®Google Scholar
• Sharif, M. and Shaheen, K.Y., 2002. Preparation of theophylline hydrogels of atactic poly(vinyl alcohol)/NaCl/H O system for drug delivery system. Journal of controlled release, 81, 367–377.
   PubMed Web of Science ®Google Scholar
• Szejtli, J., 1998. Introduction and general overview of cyclodextrin chemistry. Chemical reviews, 98 (5), 1743–1754.
   PubMed Web of Science ®Google Scholar
• Terekhova, I.V., Volkova, T.V., and Perlovich, G.L., 2007. Interactions of theophylline with cyclodextrins in water. Mendeleev communications, 17 (4), 244–246.
   Web of Science ®Google Scholar
• Uekama, K., Hirayama, F., and Irie, T., 1998. Cyclodextrin drug carrier systems. Chemical reviews, 98 (5), 2045–2076.
   PubMed Web of Science ®Google Scholar
• Valle, E.M.M.D. 2004. Cyclodextrins and their uses: a review. Process biochemistry, 39, 1033–1046.
   Web of Science ®Google Scholar
• Vos, T., et al., 2015. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study. Lancet, 386 (9995), 743–800.
   PubMed Web of Science ®Google Scholar
• Waters, V. and Smyth, A., 2015. Cystic fibrosis microbiology: advances in antimicrobial therapy. Journal of cystic fibrosis, 14 (5), 551–560.
   PubMed Web of Science ®Google Scholar
• Wei, Y.-L., et al., 2003. Study on inclusion complex of cyclodextrin with methyl xanthine derivatives by fluorimetry. Spectrochimica acta. Part A, molecular and biomolecular spectroscopy, 59 (12), 2697–2703.
   PubMed Web of Science ®Google Scholar
• Wen, X., et al., 2004. Preparation and study the 1:2 inclusion complex of carvedilol with beta-cyclodextrin. Journal of pharmaceutical and biomedical analysis, 34 (3), 517–523.
   PubMed Web of Science ®Google Scholar
• Whitwhurst, V.E., et al., 1996. Reversal of acute theophylline toxicity by calcium channel blockers in dogs and rats. Toxicology, 110, 113–121.
   PubMed Web of Science ®Google Scholar
• Zhao, D., et al., 2002. Study of the supramolecular inclusion of β-cyclodextrin with andrographolide. Journal of inclusion phenomena and macrocyclic chemistry, 43 (3/4), 259–264.
   Web of Science ®Google Scholar